Correlation Between Phio Pharmaceuticals and Vir Biotechnology
Can any of the company-specific risk be diversified away by investing in both Phio Pharmaceuticals and Vir Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Phio Pharmaceuticals and Vir Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Phio Pharmaceuticals Corp and Vir Biotechnology, you can compare the effects of market volatilities on Phio Pharmaceuticals and Vir Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Phio Pharmaceuticals with a short position of Vir Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Phio Pharmaceuticals and Vir Biotechnology.
Diversification Opportunities for Phio Pharmaceuticals and Vir Biotechnology
0.57 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Phio and Vir is 0.57. Overlapping area represents the amount of risk that can be diversified away by holding Phio Pharmaceuticals Corp and Vir Biotechnology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vir Biotechnology and Phio Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Phio Pharmaceuticals Corp are associated (or correlated) with Vir Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vir Biotechnology has no effect on the direction of Phio Pharmaceuticals i.e., Phio Pharmaceuticals and Vir Biotechnology go up and down completely randomly.
Pair Corralation between Phio Pharmaceuticals and Vir Biotechnology
Given the investment horizon of 90 days Phio Pharmaceuticals Corp is expected to generate 2.83 times more return on investment than Vir Biotechnology. However, Phio Pharmaceuticals is 2.83 times more volatile than Vir Biotechnology. It trades about 0.11 of its potential returns per unit of risk. Vir Biotechnology is currently generating about -0.25 per unit of risk. If you would invest 129.00 in Phio Pharmaceuticals Corp on January 9, 2025 and sell it today you would earn a total of 25.00 from holding Phio Pharmaceuticals Corp or generate 19.38% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Phio Pharmaceuticals Corp vs. Vir Biotechnology
Performance |
| Timeline |
| Phio Pharmaceuticals Corp |
| Vir Biotechnology |
Phio Pharmaceuticals and Vir Biotechnology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Phio Pharmaceuticals and Vir Biotechnology
The main advantage of trading using opposite Phio Pharmaceuticals and Vir Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Phio Pharmaceuticals position performs unexpectedly, Vir Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vir Biotechnology will offset losses from the drop in Vir Biotechnology's long position.| Phio Pharmaceuticals vs. Zura Bio Limited | Phio Pharmaceuticals vs. Immix Biopharma | Phio Pharmaceuticals vs. Cns Pharmaceuticals | Phio Pharmaceuticals vs. ZyVersa Therapeutics |
| Vir Biotechnology vs. CureVac NV | Vir Biotechnology vs. Krystal Biotech | Vir Biotechnology vs. Propanc Biopharma | Vir Biotechnology vs. Blueprint Medicines Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Other Complementary Tools
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |